Leveraging Our Expertise to Unleash
the Potential of Personalized Medicine
Supports major multiple myeloma personalized medicine programs
Committed Advocates Supporting
Positive Growth in the Clinical Trials Industry
Actively participates in industry forums
Powerful Clinical Research Meets Innovation
ACT Oncology is a specialty oncology CRO with a clear and consistent focus on supporting cutting-edge clinical research to advance treatments for cancer. We believe in the power of our Sponsors’ novel science, combined with our clinical operations experience and oncology research expertise. We apply metrics-driven project management to optimize multinational oncology clinical research through dedicated and highly experienced teams.
With ACT Oncology, clients can expect:
- Expert strategic development planning, therapeutic alignment and superior project execution for the most complex oncology studies
- Empowered, responsive and consistent project teams
- Flexible and scalable services to meet the changing needs of each program
- Focus on meeting or exceeding timelines, within budget
- On-going project risk evaluation and mitigation
Our significant project management experience and oncology expertise, combined with a passionate commitment to science and client service are key attributes of ACT Oncology. We invite you to partner with us and together we can enhance the management of your oncology development programs.
Stop by to see us at ASCO - Booth #23153 - to hear exciting announcements and learn how ACT Oncology is accelerating the early development research process.
ACT Oncology is Hiring!
ACT Oncology provides excellent clinical trial services to our clients. As a result, we are experiencing tremendous growth and looking for various types of experienced individuals to join our Team.
As a founding principle, we have an uncompromising passion for quality. It is who we are.
We believe that integrity is an essential asset. We will always do the right thing.
We are advocates of our Sponsors’ goals for the advancement of oncology treatment options.